562 related articles for article (PubMed ID: 2503557)
1. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
2. Absence of homologous restriction factor does not affect CTL-mediated cytolysis.
Krähenbühl OP; Peter HH; Tschopp J
Eur J Immunol; 1989 Jan; 19(1):217-9. PubMed ID: 2784107
[TBL] [Abstract][Full Text] [Related]
3. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
4. Resistance of mouse cytolytic cells to pore-forming protein-mediated cytolysis.
Shinkai Y; Ishikawa H; Hattori M; Okumura K
Eur J Immunol; 1988 Jan; 18(1):29-33. PubMed ID: 3345794
[TBL] [Abstract][Full Text] [Related]
5. Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins.
Jiang SB; Ojcius DM; Persechini PM; Young JD
J Immunol; 1990 Feb; 144(3):998-1003. PubMed ID: 2104915
[TBL] [Abstract][Full Text] [Related]
6. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
8. Target cell lysis by cytotoxic T lymphocytes that lack detectable hemolytic perforin activity.
Allbritton NL; Nagler-Anderson C; Elliott TJ; Verret CR; Eisen HN
J Immunol; 1988 Nov; 141(10):3243-8. PubMed ID: 3263417
[TBL] [Abstract][Full Text] [Related]
9. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
10. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
11. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin.
Müller C; Tschopp J
J Immunol; 1994 Sep; 153(6):2470-8. PubMed ID: 7521362
[TBL] [Abstract][Full Text] [Related]
12. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
Bajpai A; Kwon BS; Brahmi Z
Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
[TBL] [Abstract][Full Text] [Related]
13. Involvement of granule proteins in T-cell-mediated cytolysis.
Krähenbühl O; Tschopp J
Nat Immun Cell Growth Regul; 1990; 9(4):274-82. PubMed ID: 2215515
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
Lowrey DM; Hameed A; Lichtenheld M; Podack ER
Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.
Schlesinger BC; Cheng L
Immunology; 1994 Feb; 81(2):291-5. PubMed ID: 8157278
[TBL] [Abstract][Full Text] [Related]
16. Serine esterase in cytolytic T lymphocytes.
Pasternack MS; Verret CR; Liu MA; Eisen HN
Nature; 1986 Aug 21-27; 322(6081):740-3. PubMed ID: 3489187
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling.
Ojcius DM; Zheng LM; Sphicas EC; Zychlinsky A; Young JD
J Immunol; 1991 Jun; 146(12):4427-32. PubMed ID: 2040805
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the lytic activity of perforin by lipoproteins.
Tschopp J; Masson D; Schäfer S
J Immunol; 1986 Sep; 137(6):1950-3. PubMed ID: 2427587
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.
Jiang S; Persechini PM; Rosse WF; Perussia B; Young JD
Biochem Biophys Res Commun; 1989 Jul; 162(1):316-25. PubMed ID: 2751655
[TBL] [Abstract][Full Text] [Related]
20. Cellular localization of perforin 1 in murine cloned cytotoxic T lymphocytes.
Groscurth P; Qiao BY; Podack ER; Hengartner H
J Immunol; 1987 May; 138(9):2749-52. PubMed ID: 3494768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
